Effect of ADRB2 (adrenergic receptor β2) gene polymorphisms on the occurrence of asthma and on the response to nebulized salbutamol in South Indian patients with bronchial asthma

References

• Barnes PJ. Asthma. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al. eds. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill Medical; 2011:2103–2104
   Google Scholar
• Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15–26
   PubMed Web of Science ®Google Scholar
• Burchard EG, Avila PC, Nazario S, Casal J, Torres A, Rodriguez-Santana JR, Toscano M, et al. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med 2004;169:386–392
   PubMed Web of Science ®Google Scholar
• Ramphul K, Lv J, Hua L, Liu QH, Fang DZ, Ji RX, Bao YX, et al. Single nucleotide polymorphisms predisposing to asthma in children of Mauritian Indian and Chinese Han ethnicity. Braz J Med Biol Res 2014;47:394–397
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research. Summary Minutes of the Pulmonary-Allergy Drugs Advisory Committee. 13 June 2005. Available from: http://www.fda.gov/ohrms/dockets/ac/05/minutes/2005-4148M1_Final.pdf [last accessed Jul 25 2014]
   Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120:S94–S138
   PubMed Web of Science ®Google Scholar
• Nisar M, Walshaw M, Earis JE, Pearson MG, Calverley PM. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 1990;45:190–194
   PubMed Web of Science ®Google Scholar
• Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000;56:1054–1070
   PubMed Web of Science ®Google Scholar
• Lipworth BJ, Basu K, Donald HP, Tavendale R, Macgregor DF, Ogston SA, et al. Tailored second-line therapy in asthmatic children with the Arg(16) genotype. Clin Sci 2013;124:521–528
   PubMed Web of Science ®Google Scholar
• Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505–1512
   PubMed Web of Science ®Google Scholar
• Kukreti R, Bhatnagar P, B-Rao C, Gupta S, Madan B, Das C, et al. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics. Pharmacogenomics 2005;6:399–410
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319–338
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948–968
   PubMed Web of Science ®Google Scholar
• Nickerson BG, Lemen RJ, Gerdes CB, Wegmann MJ, Robertson G. Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis 1980;122:859–866
   PubMed Web of Science ®Google Scholar
• Hansen JE, Sun XG, Adame D, Wasserman K. Argument for changing criteria for bronchodilator responsiveness. Respir Med 2008;102:1777–1783
   PubMed Web of Science ®Google Scholar
• Alberts WM, Goldman AL, Leaverton PE. Bronchodilator testing “confidence intervals” based on the level of bronchial responsiveness. Chest 1992;102:737–741
   PubMed Web of Science ®Google Scholar
• Tweeddale PM, Merchant S, Leslie M, Alexander F, McHardy GJ. Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits. Thorax 1984;39:928–932
   PubMed Web of Science ®Google Scholar
• Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334–339
   PubMed Web of Science ®Google Scholar
• Zheng BQ, Wang GL, Yang S, Lu YQ, Liu RJ, Li Y. Study of genetic susceptibility in 198 children with asthma [Abstract]. Chin J Contemp Pediatr 2012;14:811–814
   Google Scholar
• Chung LP, Baltic S, Ferreira M, Temple S, Waterer G, Thompson PJ. Beta2 adrenergic receptor (ADRβ2) haplotype pair (2/4) is associated with severe asthma. PLoS One 2014;9:e93695
   PubMedGoogle Scholar
• Syamsu, Yusuf I, Budu, Patellongi I. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients. Acta Medica Indones 2007;39:8–12
   PubMedGoogle Scholar
• Migita O, Noguchi E, Jian Z, Shibasaki M, Migita T, Ichikawa K, et al. ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis. Int Arch Allergy Immunol 2004;134:150–157
   PubMed Web of Science ®Google Scholar
• Santillan AA, Camargo CA, Ramirez-Rivera A, Delgado-Enciso I, Rojas-Martinez A, Cantu-Diaz F, et al. Association between β2-adrenoceptor polymorphisms and asthma diagnosis among Mexican adults. J Allergy Clin Immunol 2003;112:1095–1100
   PubMed Web of Science ®Google Scholar
• Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414–9419
   PubMed Web of Science ®Google Scholar
• Moore PE, Laporte JD, Abraham JH, Schwartzman IN, Yandava CN, Silverman ES, et al. Polymorphism of the beta(2)-adrenergic receptor gene and desensitization in human airway smooth muscle. Am J Respir Crit Care Med 2000;162:2117–2124
   PubMed Web of Science ®Google Scholar
• Karam RA, Sabbah NA, Zidan HE, Rahman HMA. Association between genetic polymorphisms of beta2 adrenergic receptors and nocturnal asthma in Egyptian children. J Investig Allergol Clin Immunol 2013;23:262–266
   PubMed Web of Science ®Google Scholar
• De Paiva AC, Marson FA, Ribeiro JD, Bertuzzo CS. Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors. Allergy Asthma Clin Immunol 2014;10:8
   PubMed Web of Science ®Google Scholar
• Oostendorp J, Postma DS, Volders H, Jongepier H, Kauffman HF, Boezen HM, et al. Differential desensitization of homozygous haplotypes of the β2-adrenergic receptor in lymphocytes. Am J Respir Crit Care Med 2005;172:322–328
   PubMed Web of Science ®Google Scholar
• McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 1998;102:1927–1932
   PubMed Web of Science ®Google Scholar
• Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000;97:10483–10488
   PubMed Web of Science ®Google Scholar
• Fu WP, Zhao ZH, Zhong L, Sun C, Fang LZ, Liu L, et al. Relationship between polymorphisms in the 5′ leader cistron, positions 16 and 27 of the adrenergic β2 receptor gene and asthma in a Han population from southwest China. Respirol 2011;16:1221–1227
   PubMed Web of Science ®Google Scholar
• Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184–3188
   PubMed Web of Science ®Google Scholar
• Carroll CL, Stoltz P, Schramm CM, Zucker AR. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations. Chest 2009;135:1186–1192
   PubMed Web of Science ®Google Scholar
• Henderson SO, Simma-Chiang V, Lee C, Calder K, Mack WJ. Asthma: effect of genotype on response to therapy in the Emergency Department. West J Emerg Med. 2007;8:73–77
   PubMedGoogle Scholar
• Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005;171:563–570
   PubMed Web of Science ®Google Scholar
• Lima JJ, Thomason DB, Mohamed MH, Eberle LV, Self TH, Johnson JA. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 1999;65:519–525
   PubMed Web of Science ®Google Scholar
• Hawkins GA, Tantisira K, Meyers DA, Ampleford EJ, Moore WC, Klanderman B, et al. Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study. Am J Respir Crit Care Med 2006;174:1101–1109
   PubMed Web of Science ®Google Scholar
• Dishy V, Landau R, Sofowora GG, Xie H-G, Smiley RM, Kim RB, et al. Beta2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo. Pharmacogenetics 2004;14:517–522
   PubMedGoogle Scholar
• Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, et al. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med 2014;2:204–213
   PubMed Web of Science ®Google Scholar
• Drake KA, Torgerson DG, Gignoux CR, Galanter JM, Roth LA, Huntsman S, et al. A genome-wide association study of bronchodilator response in Latinos implicates rare variants. J Allergy Clin Immunol 2014;133:370–378
   PubMed Web of Science ®Google Scholar
• Holloway JW, Dunbar PR, Riley GA, Sawyer GM, Fitzharris PF, Pearce N, et al. Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000;30:1097–1103
   PubMed Web of Science ®Google Scholar
• Naghan PA, Fahimi F, Nadji SA, Naderi N, Soleimani F, Masjedi MR. A pilot study of polymorphism of adrenergic Beta-2 receptor and mild asthma: a clinical and pharmacogenetic study. Iran J Pharm Res 2013;12:199–204
   Web of Science ®Google Scholar